Eqis Capital Management, Inc. Durect Corp Transaction History

Eqis Capital Management, Inc.

  • $1.21 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 24, 2022
SELL
$0.43 - $5.9 $1,118 - $15,340
-2,600 Reduced 3.9%
64,042 $0
Q2 2022

Aug 08, 2022
SELL
$0.38 - $0.64 $45 - $76
-120 Reduced 0.18%
66,642 $31,000
Q1 2022

May 16, 2022
BUY
$0.55 - $0.98 $36,719 - $65,426
66,762 New
66,762 $45,000

Others Institutions Holding DRRX

# of Institutions
3
Shares Held
593K
Call Options Held
0
Put Options Held
0
View Full List

About DURECT CORP

DRRX Quotes by TradingView
  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $230M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track Eqis Capital Management, Inc. Portfolio

Follow Eqis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email